Shares of Inovio Pharmaceuticals Inc. INO shed 1.18% to $6.69 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 2 ...

today announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes. This reconstitution became effective after the close of the US equities ...

COVID-19’s impact on global society would be felt for a long time. Nonetheless, significant investment in life sciences in the last few decades has facilitated a rapid scientific response through ...

At a median follow-up of 18 months, the OS rate was 95% and the DFS rate was 88%. 14 Long-term follow-up at a median of 53 ...

As of 13 September at 10:16 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

As of 13 September at 15:06 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Since 2014, when volunteer management began in most of Sheffield’s suburban libraries, and despite dire predictions from the scheme’s detractors, none of the libraries that passed into volunteer hands ...

Sailors, exiles, merchants and philosophers: how the ancient Greeks played with language to express a seaborne imagination ...

The Royal Ocean Racing Club's finale for the 2024 RORC Season's Points Championship was the traditional race to ...

The stock's fall snapped a six-day winning streak.

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, ...